C4684774_NCI_CDISC-GLOSS | Knowledge4COVID-19

Property	Value
?:definition	Information related to a serious adverse drug experience associated with use of a drug and derived from-(a) a clinical trial; (b) adverse event reports; (c) a post-approval study; (d) peer-reviewed biomedical literature; (e) data derived from the post-market REMs. [505-1(b) of FD&C Act (21 USC. 355-1(b)]
?:hasCUIAnnotation	<https://research.tib.eu/covid-19/entity/C4684774>
?:hasGeneratedBy	<https://research.tib.eu/covid-19/SourceName/NCI_CDISC-GLOSS>
?:type	<https://research.tib.eu/covid-19/vocab/AnnotationDefinition>

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/C4684774_NCI_CDISC-GLOSS>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/C4684774_NCI_CDISC-GLOSS>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all